House appropriators might get the chance to rethink funding priorities for FDA, especially as the House Appropriations Committee, which will still be led by Democrats, faces leadership changes and appropriators face the possibility of having to reconsider a previously House-passed fiscal 2021 funding bill. There’s still uncertainty about which party controls the Senate, as of Thursday afternoon (Nov. 5), but sources say if Democrats take the lead, they could seek more funding for domestic programs at FDA. If Congress doesn’t...